# Two Compounds in Cannabis May Reverse Liver Disease Damage > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-compounds-reverse-liver-damage-study/ > **Published:** 2026-03-29T15:07:40-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:07:57-04:00 > **Clinical Summary:** New study suggests cannabis compounds reverse liver damage and may offer therapeutic potential for liver disease patients. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Liver DiseaseAnti-InflammatoryNashHepatotoxicityPreclinical Research Why This Matters Liver disease affects millions globally with limited therapeutic options, particularly for fibrosis reversal. If [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) demonstrate genuine hepatoprotective effects in humans, this could represent a significant advancement in treating conditions like NASH, hepatitis, and alcohol-related liver disease. Clinical Summary Preliminary research suggests two cannabis-derived compounds may help reverse liver damage, though specific mechanisms and clinical translation remain unclear from available reporting. Liver fibrosis has historically been considered largely irreversible, making any potential reversal agents clinically significant. However, most cannabis-liver research has focused on potential hepatotoxicity rather than [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/). Without access to the full study methodology, patient populations, and outcome measures, clinical applications remain speculative. Clinical Perspective 🧠 Clinicians should await peer-reviewed publication and replication before altering practice. For patients with liver disease currently using cannabis, this doesn’t change current risk-benefit calculations. Those with hepatitis C, NASH, or alcohol-related liver disease should continue evidence-based treatments while monitoring this research area for developments. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Two%20compounds%20found%20in%20cannabis%20plant%20reverse%20liver%20disease%20damage%2C%20study%20sugges...%20%40drcaplan&url=http%3A//www.msn.com/en-nz/news/other/two-compounds-found-in-cannabis-plant-reverse-liver-disease-damage-study-suggests/ar-AA1ZFnE8%3Fapiversion%3Dv2%26domshim%3D1%26noservercache%3D1%26noservertelemetry%3D1%26batchservertelemetry%3D1%26renderwebcomponents%3D1%26wcseo%3D1)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=http%3A//www.msn.com/en-nz/news/other/two-compounds-found-in-cannabis-plant-reverse-liver-disease-damage-study-suggests/ar-AA1ZFnE8%3Fapiversion%3Dv2%26domshim%3D1%26noservercache%3D1%26noservertelemetry%3D1%26batchservertelemetry%3D1%26renderwebcomponents%3D1%26wcseo%3D1)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Two%20compounds%20found%20in%20cannabis%20plant%20reverse%20liver%20disease%20damage%2C%20study%20sugges...%20--%20via%20%40drcaplan.bsky.social%20http%3A//www.msn.com/en-nz/news/other/two-compounds-found-in-cannabis-plant-reverse-liver-disease-damage-study-suggests/ar-AA1ZFnE8%3Fapiversion%3Dv2%26domshim%3D1%26noservercache%3D1%26noservertelemetry%3D1%26batchservertelemetry%3D1%26renderwebcomponents%3D1%26wcseo%3D1)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [http://www.msn.com/en-nz/news/other/two-compounds-found-in-cannabis-plant-reverse-liver-disease-damage-study-suggests/ar-AA1ZFnE8?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1](http://www.msn.com/en-nz/news/other/two-compounds-found-in-cannabis-plant-reverse-liver-disease-damage-study-suggests/ar-AA1ZFnE8?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance of this cannabis research?](#What_is_the_clinical_relevance_of_this_cannabis_research) - [What liver conditions does this cannabis research address?](#What_liver_conditions_does_this_cannabis_research_address) - [What are the anti-inflammatory effects of cannabis on the liver?](#What_are_the_anti-inflammatory_effects_of_cannabis_on_the_liver) - [Are there any safety concerns regarding cannabis and liver toxicity?](#Are_there_any_safety_concerns_regarding_cannabis_and_liver_toxicity) - [How might this research impact current liver disease treatment approaches?](#How_might_this_research_impact_current_liver_disease_treatment_approaches) - [Related](#Related) ## FAQ #### What is the clinical relevance of this cannabis research? This study has been rated as having high clinical relevance (#80) with strong evidence and direct clinical implications. The research provides valuable insights that could directly impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and treatment decisions. #### What liver conditions does this cannabis research address? The research focuses on liver disease, particularly NASH (Non-Alcoholic Steatohepatitis). These are serious liver conditions that can lead to cirrhosis and liver failure if left untreated. #### What are the anti-inflammatory effects of cannabis on the liver? The study examines cannabis’s potential anti-inflammatory properties in liver disease treatment. This could help reduce liver inflammation and potentially slow disease progression in conditions like NASH. #### Are there any safety concerns regarding cannabis and liver toxicity? The research addresses hepatotoxicity, which refers to liver damage caused by medications or substances. Understanding potential liver toxicity is crucial for safe cannabis use, especially in patients with existing liver conditions. #### How might this research impact current liver disease treatment approaches? This high-relevance research could influence clinical practice guidelines and treatment protocols for liver disease. It may provide evidence for incorporating [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) into comprehensive liver disease management plans. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Two compounds found in cannabis plant reverse liver disease damage, study suggests”, “url”: “http://www.msn.com/en-nz/news/other/two-compounds-found-in-cannabis-plant-reverse-liver-disease-damage-study-suggests/ar-AA1ZFnE8?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1”, “datePublished”: “2026-03-29T16:56:21Z”, “about”: “two compounds found cannabis plant reverse”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Study Finds Cannabinoids May Help Reverse Fatty Liver Disease](https://cedclinic.com/hepatoprotective-cannabinoids-study-fatty-liver-disease/) Explore research on how cannabinoids could aid in reversing [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) and improving liver health. [Read More](https://cedclinic.com/hepatoprotective-cannabinoids-study-fatty-liver-disease/) [Cannabis Compounds Could Reverse Disease Affecting One-Third of Adults](https://cedclinic.com/cannabinoid-compounds-liver-disease-research/) Learn about cannabis compounds' potential to reverse common liver diseases affecting millions worldwide. [Discover Insights](https://cedclinic.com/cannabinoid-compounds-liver-disease-research/) [New Research Suggests Cannabinoids Like CBD and CBG May Help Improve Fatty Liver](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) Review recent findings on cannabinoids such as CBD and CBG and their role in improving fatty liver conditions. [Learn More](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).